MEDICAL SCIENCES. For the article “Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β,” by Bibiana Bielekova, Nancy Richert, Thomas Howard, Gregg Blevins, Silva Markovic-Plese, Jennifer McCartin, Jens Würfel, Joan Ohayon, Thomas A. Waldmann, Henry F. McFarland, and Roland Martin, which appeared in issue 23, June 8, 2004, of Proc. Natl. Acad. Sci. USA (101, 8705–8708; first published May 25, 2004; 10.1073/pnas.0402653101), the authors request that Joseph A. Frank, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD 20892-1074, be added to the author list between Jennifer McCartin and Jens Würfel. The online version has been corrected. The corrected author and affiliation lines appear below.
Bibiana Bielekova*, Nancy Richert*, Thomas Howard*, Gregg Blevins*, Silva Markovic-Plese*†, Jennifer McCartin*, Joseph A. Frank‡, Jens Würfel*§, Joan Ohayon*, Thomas A. Waldmann¶, Henry F. McFarland*, and Roland Martin*∥
*Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892; †Department of Neurology, University of North Carolina at Chapel Hill, 6109 Neuroscience Research Building, Chapel Hill, NC 27599; ‡Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD 20892-1074; §Institute of Neuroimmunology, Charité, Humboldt-University Berlin, Schumannstrasse 20/21, D-10117 Berlin, Germany; and ¶Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
∥To whom correspondence should be addressed at: Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, MSC 1400, Bethesda, MD 20892. E-mail: martinr@ninds.nih.gov.